Apyx Medical Corp. Files 8-K on Financials
Ticker: APYX · Form: 8-K · Filed: Mar 21, 2024 · CIK: 719135
| Field | Detail |
|---|---|
| Company | Apyx Medical Corp (APYX) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations
TL;DR
Apyx Medical Corp. just dropped an 8-K detailing their financial condition and operations.
AI Summary
Apyx Medical Corp. filed an 8-K on March 21, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to its business operations. The company, formerly known as BOVIE MEDICAL Corp, is incorporated in Delaware and headquartered in Clearwater, Florida.
Why It Matters
This filing provides investors with updated financial information and operational details for Apyx Medical Corp., crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Apyx Medical Corp. (company) — Registrant
- BOVIE MEDICAL Corp (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Clearwater, Florida (location) — Principal executive offices
- March 21, 2024 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for Apyx Medical Corp.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, including financial statements and exhibits.
When was this 8-K filed?
This 8-K was filed on March 21, 2024.
What was Apyx Medical Corp. formerly known as?
Apyx Medical Corp. was formerly known as BOVIE MEDICAL Corp.
Where are Apyx Medical Corp.'s principal executive offices located?
Apyx Medical Corp.'s principal executive offices are located at 5115 Ulmerton Road, Clearwater, Florida 33760.
Under which state is Apyx Medical Corp. incorporated?
Apyx Medical Corp. is incorporated in Delaware.
Filing Stats: 490 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-03-21 07:06:43
Filing Documents
- apyx-20240321.htm (8-K) — 25KB
- a2023q4apyxex991earningsre.htm (EX-99.1) — 223KB
- apyx-20240321_g1.jpg (GRAPHIC) — 116KB
- apyx-medicalxregxwxtaglinea.jpg (GRAPHIC) — 116KB
- image3a.jpg (GRAPHIC) — 79KB
- 0000719135-24-000013.txt ( ) — 936KB
- apyx-20240321.xsd (EX-101.SCH) — 2KB
- apyx-20240321_lab.xml (EX-101.LAB) — 21KB
- apyx-20240321_pre.xml (EX-101.PRE) — 12KB
- apyx-20240321_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On March 21, 2024, Apyx Medical Corporation (the "Company") issued a press release reporting on its results of operations for the fourth quarter and year ended December 31, 2023. A copy of that press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. This information is intended to be furnished under Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 99.1 Earnings press release dated March 21, 2024
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 21, 2024 Apyx Medical Corporation By: /s/ Matthew Hill Matthew Hill Chief Financial Officer, Secretary and Treasurer